semaglutide
Cut Heart Risk Savings Semaglutide Wins Over Tirzepatide
Yes, recent clinical evidence shows semaglutide lowers the risk of heart attacks in adults with type 2 diabetes, while tirzepatide also demonstrates cardiovascular benefit but with a different magnitude. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional